the effect of dexamethasone therapy in septic arthritis treatment

Comparaing the effect of dexamethasone therapy versus placebo in septic arthritis treatment

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013112011014N1

Enrollment

Registered

2013-11-20

Start date

2012-07-17

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic arthritis. Pyogenic arthritis

Interventions

Intervention 1: 15 cc/kg. Intervention 2: Injected or not injected with dexamethasone.

Treatment - Drugs

15 cc/kg

Injected or not injected with dexamethasone

Eligibility

Sex/Gender

All

Age

1 Years to 15 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age above 6 months; patient with septic arthritis from first time. Exclusion criteria: history of immunosuppressive disease or leukemia; history of systemic disease; use of antibiotic therapy before culture; use of systemic corticosteroid before diseas; history of systemic inflamatory disease such as rheumatoid arthritis.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Duration of teratment. Timepoint: daily. Method of measurement: number day stay in hospital.	—

Secondary

Measure	Time frame
Number of day that need CRPbecom normal. Timepoint: every three day. Method of measurement: from+ to+++++.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Arti

Ahvaz Jundishapur University of Medical Sciences

hamidrezaarti@gmail.com+98 61 1322 5463

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026